Winner of the 2025 Outstanding Cancer Researcher of the Year Award

Professor Keall is an NHMRC Leadership Fellow and the Director of the Image X Institute at the University of Sydney.

Paul Keall is a Professor in the Faculty of Medicine and Health at the University of Sydney, an NHMRC Leadership Fellow and the Director of the Image X Institute. He was previously the Director of Radiation Physics at Stanford University. He returned to Sydney as an NHMRC Australia Fellow, one of only 39 people given this award. 

His contributions to cancer research are internationally recognised. He has been ranked #1 worldwide from over 10,000 scientists and clinicians in Image Guided Radiotherapy by ExpertScape. Technology he pioneered, notably ‘4D CT’ to image lungs during breathing, is the global clinical standard for lung cancer radiotherapy patients and has improved the lives of millions of patients. His team have also invented technologies that have been used in eight first-in-human trials to improve cancer imaging and targeted radiation therapy. Outputs from his research include multiple bench-to-bedside clinical trials, over 400 scientific publications, and over 350 invited lectures. 

He works closely with industry to ensure his research has real-world impact with 29current and completed industrial research agreements. His 42 awarded or in-process patents for medical devices have led to 20 inventions being licensed or assigned to ten companies, resulting in five global products to date. He has founded three start-up companies that have developed, or are developing, medical devices for cancer imaging and targeted radiation therapy.